Champions Oncology to Present New Data on Predicting Response and Resistance at AACR 2026
-
China's Wu wins last-frame thriller to reach snooker world final
-
Verstappen sees light at the end of tunnel
-
Young stretches PGA lead to six at Doral
-
Rio's Copacabana beach hosts massive crowd for free Shakira concert
-
Celtics' Tatum ruled out for decisive game seven against Sixers
-
Wolff heralds Antonelli speed as teen joins Senna and Schumacher in record books
-
Senior Iranian officer says fresh conflict with US 'likely'
-
Barcelona on verge of Liga title, Villarreal secure top four
-
Teen F1 leader Antonelli takes Miami Grand Prix pole
-
Porto edge Alverca to clinch Portuguese league title
-
US airlines step up as Spirit winds down
-
Barcelona on verge of La Liga title defence with win at Osasuna
-
Drugmaker asks US Supreme Court to restore abortion pill access
-
Schalke return to Bundesliga after three-year absence
-
NATO, top Republicans question US troop withdrawal from Germany
-
Napoli frustrate Como in costly Serie A stalemate
-
Illegal party at French military site draws up to 40,000 ravers
-
Arsenal hit stride to go six points clear, West Ham loss offers Spurs hope
-
Arsenal go six points clear as Gyokeres double sinks Fulham
-
Clinical Chennai down Mumbai to keep playoff hopes alive
-
Napoli and Como play out goalless draw in Serie A
-
Murphy into World Snooker Championship final after edging Higgins
-
PSG held by Lorient with fringe team ahead of Bayern Munich return leg
-
Aviation companies step up as Spirit winds down
-
Champion Norris leads Piastri home in sprint 1-2 triumph for McLaren
-
UK PM says some pro-Palestinian marches could be banned
-
The Puma out of Kentucky Derby, leaving 19 starters
-
'Bookless bookstore': audio-only book shop opens in New York
-
Kostyuk defeats Andreeva to claim first Madrid Open title
-
Leinster survive Toulon scare to reach Champions Cup final
-
Villarreal secure Champions League spot, rotated Atletico win
-
'Relieved' Inoue outlasts Nakatani in Tokyo Dome superfight
-
Israel quizzes two Gaza flotilla activists, angering Spain
-
West Ham defeat gives Spurs hope, Arsenal face Fulham test
-
Second-string Bayern held by Heidenheim before PSG clash
-
Lyon edge Arsenal to reach women's Champions League final
-
Struggling Nantes deepen Marseille's woes in Ligue 1
-
Harmanpreet Kaur to lead India in women's T20 World Cup
-
Pogacar wins again to pull clear in Tour of Romandie
-
New Zealand win rain-hit T20 to end Bangladesh series 1-1
-
Inoue outlasts Nakatani in Tokyo Dome superfight
-
Taiwan leader makes delayed visit to Eswatini after China objections
-
Iran military official says renewed war with US 'likely'
-
Coe will be 'tough' on athletes seeking nationality switch
-
Illegal rave draws 20,000 to 'dangerous' military site in France
-
US rapper Kanye West to perform in Albania in July
-
Ex-F1 driver turned Paralympic champion Zanardi dies
-
In Vietnam, Japan PM vows more effort to keep Asia 'free and open'
-
Humpback whale stranded in Germany released into North Sea: media
-
Japan PM meets top Vietnam leaders in Hanoi
Champions Oncology to Present New Data on Predicting Response and Resistance at AACR 2026
Eight studies demonstrate how clinically relevant models and integrated data can reduce translational risk and guide development decisions
HACKENSACK, NJ / ACCESS Newswire / April 9, 2026 / Champions Oncology, Inc. (Nasdaq:CSBR), a global leader in clinically relevant oncology research models and translational solutions, today announced it will present new data across eight poster presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting, taking place April 17-22, 2026, in San Diego, California.
The presentations will highlight research across key areas of oncology drug development, including KRAS-mutant tumors, ovarian cancer, glioblastoma, radiopharmaceuticals, antibody-drug conjugates (ADCs), and CAR-T therapies. Together, the data underscore Champions Oncology's focus on helping biopharma partners better understand therapeutic response and resistance, identify actionable biomarkers, and make more informed development decisions earlier in the pipeline.
Using clinically relevant, patient-derived models together with integrated molecular, functional, and phenotypic data, the studies demonstrate how translationally relevant preclinical approaches can improve prediction, reduce development risk, and strengthen the connection between tumor biology and clinical strategy.
"At AACR 2026, we are presenting data that directly address one of the biggest challenges in oncology R&D, making better decisions earlier," said Rob Brainin, Chief Executive Officer of Champions Oncology. "By combining clinically relevant models with deep molecular and functional data, we can help our partners understand response, anticipate resistance, and move forward with greater confidence."
Champions Oncology scientists will be available throughout AACR 2026 to discuss study design, analytical approaches, and collaboration opportunities.
For more information on Champions Oncology's presence at AACR 2026, including poster details and meeting opportunities, visit: https://www.championsoncology.com/meet-us-at-aacr-2026
Contact Information
Gavin Cooper
Vice President, Global Marketing
(518) 488-9062
SOURCE: Champions Oncology, Inc.
View the original press release on ACCESS Newswire
F.Pedersen--AMWN